TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 3 | 6 | 14 | 21 | 32 | -17 | 10 |
| P | %wins | 50 | 50 | 50 | 50 | 100 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/14 10:34 | 9/2/14 | STML | Stemline Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Zuerblis Kenneth J | NY | D | P | 11 | 11.14 | 2 | 1 | 9 | 12 | D | -68 | -59 | -24 | -12 | -4 | -3 | -2 | -1 | 33 | 16 | 36 | 46 | -16 | ||
6/3/13 07:59 | 5/29/13 | STML | Stemline Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Zuerblis Kenneth J | NY | D | P.m | 48 | 16.01 | 2 | 3 | 11 | 31 | I | 49 | 36 | 24 | 17 | 9 | -2 | -6 | 47 | 107 | 17 | -17 | ||||
11/21/11 12:06 | 11/18/11 | SVNT | Savient Pharmaceuticals Inc | DE | Health | MdCm | Medicinal Chemicals & Botanic | Zuerblis Kenneth J | NJ | O | EVP,CFO | P | 5 | 2.35 | 5 | 2 | 40 | 7 | D | -83 | -81 | -70 | -39 | -39 | -37 | -21 | -8 | 7 | -3 | -5 | -10 | ||
9/16/11 19:05 | 9/14/11 | SVNT | Savient Pharmaceuticals Inc | DE | Health | MdCm | Medicinal Chemicals & Botanic | Zuerblis Kenneth J | NJ | O | EVP,CFO | P.m | 20 | 4.03 | 6 | 5 | New | 5 | D | -74 | -80 | -56 | -41 | -11 | 6 | 11 | 8 | 6 | 0 | -3 | -50 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |